Diasorin announced that it has received 510(k) clearance from the FDA for the Simplexa COVID-19 / Flu A/B & RSV Direct kit, a sample-to-answer test for the detection of SARS-CoV-2, influenza A virus, influenza B virus, and RSV directly from nasopharyngeal and nasal swab specimens.
